The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 34,268 | 510,010 | SH | SOLE | 510,010 | 0 | 0 | ||
| ADURO BIOTECH INC | COM | 00739L101 | 1,870 | 61,639 | SH | SOLE | 61,639 | 0 | 0 | ||
| AETNA INC NEW | COM | 00817Y108 | 33,659 | 264,075 | SH | SOLE | 264,075 | 0 | 0 | ||
| ALERE INC | COM | 01449J105 | 24,327 | 461,170 | SH | SOLE | 461,170 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 41,519 | 136,818 | SH | SOLE | 136,818 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 89,110 | 6,297,523 | SH | SOLE | 6,297,523 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | COM | 04269X105 | 98,226 | 13,623,620 | SH | SOLE | 13,623,620 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | NOTE 3.000% 6/0 | 04269XAA3 | 5,050 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | ||
| ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 19,661 | 372,642 | SH | SOLE | 372,642 | 0 | 0 | ||
| AVALANCHE BIOTECHNOLOGIES IN | COM | 05337G107 | 8,725 | 537,282 | SH | SOLE | 537,282 | 0 | 0 | ||
| AXOVANT SCIENCES LTD | COM | G0750W104 | 3,057 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 5,065 | 238,121 | SH | SOLE | 238,121 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 31,959 | 79,118 | SH | SOLE | 79,118 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 28,415 | 207,744 | SH | SOLE | 207,744 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 9,671 | 378,235 | SH | SOLE | 378,235 | 0 | 0 | ||
| CASTLIGHT HEALTH INC | CL B | 14862Q100 | 16,155 | 1,984,631 | SH | SOLE | 1,984,631 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM | 15117B103 | 826 | 32,765 | SH | SOLE | 32,765 | 0 | 0 | ||
| CERUS CORP | COM | 157085101 | 8,322 | 1,603,427 | SH | SOLE | 1,603,427 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 3,920 | 476,293 | SH | SOLE | 476,293 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 32,313 | 699,425 | SH | SOLE | 699,425 | 0 | 0 | ||
| CIGNA CORPORATION | COM | 125509109 | 32,189 | 198,700 | SH | SOLE | 198,700 | 0 | 0 | ||
| CIVITAS SOLUTIONS INC | COM | 17887R102 | 14,029 | 657,693 | SH | SOLE | 657,693 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 66,743 | 759,479 | SH | SOLE | 759,479 | 0 | 0 | ||
| DAVITA HEALTHCARE PARTNERS I | COM | 23918K108 | 11,141 | 140,191 | SH | SOLE | 140,191 | 0 | 0 | ||
| ELEVEN BIOTHERAPEUTICS INC | COM | 286221106 | 3,557 | 1,261,260 | SH | SOLE | 1,261,260 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 12,988 | 2,007,446 | SH | SOLE | 2,007,446 | 0 | 0 | ||
| FLEXION THERAPEUTICS INC | COM | 33938J106 | 3,119 | 142,483 | SH | SOLE | 142,483 | 0 | 0 | ||
| FLUIDIGM CORP DEL | COM | 34385P108 | 8,427 | 348,237 | SH | SOLE | 348,237 | 0 | 0 | ||
| GENOCEA BIOSCIENCES INC | COM | 372427104 | 8,561 | 623,519 | SH | SOLE | 623,519 | 0 | 0 | ||
| GW PHARMACEUTICALS PLC | ADS | 36197T103 | 17,938 | 146,027 | SH | SOLE | 146,027 | 0 | 0 | ||
| HCA HOLDINGS INC | COM | 40412C101 | 35,381 | 390,000 | SH | SOLE | 390,000 | 0 | 0 | ||
| HEALTH NET INC | COM | 42222G108 | 24,887 | 388,128 | SH | SOLE | 388,128 | 0 | 0 | ||
| INCYTE CORP | COM | 45337C102 | 17,194 | 164,995 | SH | SOLE | 164,995 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 21,181 | 867,346 | SH | SOLE | 867,346 | 0 | 0 | ||
| INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 19,495 | 610,171 | SH | SOLE | 610,171 | 0 | 0 | ||
| INVITAE CORP | COM | 46185L103 | 2,563 | 181,224 | SH | SOLE | 181,224 | 0 | 0 | ||
| ISHARES | US HLTHCR PR ETF | 464288828 | 1,229 | 8,599 | SH | SOLE | 8,599 | 0 | 0 | ||
| JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 26,563 | 150,866 | SH | SOLE | 150,866 | 0 | 0 | ||
| KYTHERA BIOPHARMACEUTICALS I | COM | 501570105 | 36,341 | 482,556 | SH | SOLE | 482,556 | 0 | 0 | ||
| MARKET VECTORS ETF TR | PHARMACEUTICAL | 57060U217 | 460 | 6,500 | SH | SOLE | 6,500 | 0 | 0 | ||
| MODEL N INC | COM | 607525102 | 17,189 | 1,443,278 | SH | SOLE | 1,443,278 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 22,509 | 1,459,742 | SH | SOLE | 1,459,742 | 0 | 0 | ||
| ONCOTHYREON INC | COM | 682324108 | 15,577 | 4,164,878 | SH | SOLE | 4,164,878 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 16,799 | 1,212,892 | SH | SOLE | 1,212,892 | 0 | 0 | ||
| PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 6,955 | 152,700 | SH | SOLE | 152,700 | 0 | 0 | ||
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 8,613 | 516,690 | SH | SOLE | 516,690 | 0 | 0 | ||
| RECEPTOS INC | COM | 756207106 | 27,406 | 144,205 | SH | SOLE | 144,205 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 21,196 | 290,350 | SH | SOLE | 290,350 | 0 | 0 | ||
| SEATTLE GENETICS INC | COM | 812578102 | 25,613 | 529,199 | SH | SOLE | 529,199 | 0 | 0 | ||
| TEVA PHARMACEUTICAL INDS LTD | ADR | 881624209 | 57,171 | 967,359 | SH | SOLE | 967,359 | 0 | 0 | ||
| TRIVASCULAR TECHNOLOGIES INC | COM | 89685A102 | 7,835 | 1,464,563 | SH | SOLE | 1,464,563 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 6,904 | 67,425 | SH | SOLE | 67,425 | 0 | 0 | ||
| UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 25,005 | 175,965 | SH | SOLE | 175,965 | 0 | 0 | ||
| VALEANT PHARMACEUTICALS INTL | COM | 91911K102 | 85,418 | 384,506 | SH | SOLE | 384,506 | 0 | 0 | ||
| ZS PHARMA INC | COM | 98979G105 | 15,874 | 302,988 | SH | SOLE | 302,988 | 0 | 0 | ||